ClinicalTrials.Veeva

Menu

The Krill Ageing Muscle Mechanisms (KAMM) Study

U

University of Glasgow

Status

Enrolling

Conditions

Sarcopenia

Treatments

Dietary Supplement: Vegetable oil
Dietary Supplement: Krill oil

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to determine the mechanisms via which krill oil supplementation increases muscle strength and whether this translates to improvements in gait and functional characteristics in older adults. The studies we will carry out will establish, in healthy older adults, the effects of 6 months of supplementation with krill oil

Objective 1) Muscle structure and function Hypothesis: Krill oil supplementation will increase muscle size and strength alongside positive changes in muscle architecture (pennation angle and fascicle length).

Objective 2) Neuromuscular control and central nervous system (CNS) function Hypothesis: Krill oil supplementation will improve Neuromuscular Junction (NMJ) transmission stability and increase central drive and intramuscular coherence, as a measure of muscle synergy.

Objective 3) Gait and functional characteristics Hypothesis: Krill oil supplementation will improve gait and functional characteristics.

Enrollment

80 estimated patients

Sex

All

Ages

65 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • body mass index (BMI) </= 30 kg/m2
  • Age >/= 65 years
  • Capacity to consent
  • Living within the Glasgow area

Exclusion criteria

  • Diabetes mellitus
  • Severe cardiovascular disease
  • Seizure disorders
  • Uncontrolled hypertension (>150/90mmHg)
  • Active cancer or cancer that has been in remission <5 years
  • Participation in any resistance exercise training within the last 6 months
  • Impairments which may limit ability to perform assessments of muscle function
  • Dementia
  • Fish/shellfish allergy
  • Taking medication known to affect muscle (e.g. steroids, Selective serotonin reuptake inhibitors) or anticoagulants (e.g. warfarin)
  • Taking omega-3 supplements in the last 3 months
  • Regularly consuming 1 or more portions of oily fish per week
  • Not able to understand English

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups, including a placebo group

Vegetable oil
Placebo Comparator group
Description:
4g/day vegetable oil for 24 weeks
Treatment:
Dietary Supplement: Vegetable oil
Krill oil
Active Comparator group
Description:
4/g/day krill oil for 24 weeks
Treatment:
Dietary Supplement: Krill oil

Trial contacts and locations

1

Loading...

Central trial contact

Stuart Gray

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems